{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:01:11Z","timestamp":1791223271664,"version":"4.1.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,10,19]],"date-time":"2007-10-19T00:00:00Z","timestamp":1192752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s10585-007-9108-4","type":"journal-article","created":{"date-parts":[[2007,10,18]],"date-time":"2007-10-18T09:17:16Z","timestamp":1192699036000},"page":"325-334","source":"Crossref","is-referenced-by-count":91,"title":["Extravasation and homing mechanisms in multiple myeloma"],"prefix":"10.1007","volume":"25","author":[{"given":"Isabelle","family":"Vande Broek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Vanderkerken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Van Camp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Van Riet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,10,19]]},"reference":[{"issue":"18","key":"9108_CR1","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","volume":"351","author":"RA Kyle","year":"2004","unstructured":"Kyle RA, Rajkumar SV (2004) Multiple myeloma. N Engl J Med 351(18):1860\u20131873","journal-title":"N Engl J Med"},{"issue":"9","key":"9108_CR2","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1182\/blood.V80.9.2326.2326","volume":"80","author":"MH Bakkus","year":"1992","unstructured":"Bakkus MH, Heirman C, Van Riet I, Van Camp B, Thielemans K (1992) Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood 80(9):2326\u20132335","journal-title":"Blood"},{"issue":"8","key":"9108_CR3","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1182\/blood.V92.8.2908","volume":"92","author":"S Yaccoby","year":"1998","unstructured":"Yaccoby S, Barlogie B, Epstein J (1998) Primary myeloma cells growing in SCID-hu mice: a model for studying the biology and treatment of myeloma and its manifestations. Blood 92(8):2908\u20132913","journal-title":"Blood"},{"issue":"10","key":"9108_CR4","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1182\/blood.V94.10.3576.422k01_3576_3582","volume":"94","author":"S Yaccoby","year":"1999","unstructured":"Yaccoby S, Epstein J (1999) The proliferative potential of myeloma plasma cells manifest in the SCID-hu host. Blood 94(10):3576\u20133582","journal-title":"Blood"},{"issue":"11","key":"9108_CR5","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/sj.leu.2403513","volume":"18","author":"K Yata","year":"2004","unstructured":"Yata K, Yaccoby S (2004) The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells. Leukemia 18(11):1891\u20131897","journal-title":"Leukemia"},{"issue":"2","key":"9108_CR6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1097-0320(19960615)26:2<113::AID-CYTO3>3.0.CO;2-H","volume":"26","author":"TE Witzig","year":"1996","unstructured":"Witzig TE, Kimlinger TK, Ahmann GJ, Katzmann JA, Greipp PR (1996) Detection of myeloma cells in the peripheral blood by flow cytometry. Cytometry 26(2):113\u2013120","journal-title":"Cytometry"},{"issue":"11","key":"9108_CR7","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.ejca.2005.12.025","volume":"42","author":"CS Mitsiades","year":"2006","unstructured":"Mitsiades CS, Mitsiades NS, Munshi NC, Richardson PG, Anderson KC (2006) The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: interplay of growth factors, their receptors and stromal interactions. Eur J Cancer 42(11):1564\u20131573","journal-title":"Eur J Cancer"},{"issue":"1","key":"9108_CR8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V91.1.3","volume":"91","author":"M Hallek","year":"1998","unstructured":"Hallek M, Bergsagel PL, Anderson KC (1998) Multiple myeloma: increasing evidence for a multistep transformation process. Blood 91(1):3\u201321","journal-title":"Blood"},{"issue":"42","key":"9108_CR9","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1038\/sj.onc.1204833","volume":"20","author":"T Hideshima","year":"2001","unstructured":"Hideshima T, Nakamura N, Chauhan D, Anderson KC (2001) Biologic sequelae of interleukin-6 induced PI3-K\/Akt signaling in multiple myeloma. Oncogene 20(42):5991\u20136000","journal-title":"Oncogene"},{"issue":"11","key":"9108_CR10","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1182\/blood.V99.11.4138","volume":"99","author":"YW Qiang","year":"2002","unstructured":"Qiang YW, Kopantzev E, Rudikoff S (2002) Insulin-like growth factor-I signaling in multiple myeloma: downstream elements, functional correlates, and pathway cross-talk. Blood 99(11):4138\u20134146","journal-title":"Blood"},{"issue":"4","key":"9108_CR11","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood-2004-07-2909","volume":"105","author":"K Podar","year":"2005","unstructured":"Podar K, Anderson KC (2005) The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications. Blood 105(4):1383\u20131395","journal-title":"Blood"},{"issue":"12","key":"9108_CR12","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.1989.7.12.1909","volume":"7","author":"R Bataille","year":"1989","unstructured":"Bataille R, Chappard D, Marcelli C, Dessauw P, Sany J, Baldet P, Alexandre C (1989) Mechanisms of bone destruction in multiple myeloma: the importance of anunbalanced process in determining the severity of lytic bone disease. J Clin Oncol 7(12):1909\u20131914","journal-title":"J Clin Oncol"},{"issue":"1","key":"9108_CR13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1365-2141.2002.03417.x","volume":"117","author":"S Roux","year":"2002","unstructured":"Roux S, Meignin V, Quillard J, Meduri G, Guiochon-Mantel A, Fermand JP, Milgrom E, Mariette X (2002) RANK (receptor activator of nuclear factor-kappaB) and RANKL expression in multiple myeloma. Br J Haematol 117(1):86\u201392","journal-title":"Br J Haematol"},{"issue":"20","key":"9108_CR14","doi-asserted-by":"crossref","first-page":"11581","DOI":"10.1073\/pnas.201394498","volume":"98","author":"RN Pearse","year":"2001","unstructured":"Pearse RN, Sordillo EM, Yaccoby S, Wong BR, Liau DF, Colman N, Michaeli J, Epstein J, Choi Y (2001) Multiple myeloma disrupts the TRANCE\/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proc Natl Acad Sci USA 98(20):11581\u201311586","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"9108_CR15","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1182\/blood.V98.13.3527","volume":"98","author":"N Giuliani","year":"2001","unstructured":"Giuliani N, Bataille R, Mancini C, Lazzaretti M, Barille S (2001) Myeloma cells induce imbalance in the osteoprotegerin\/osteoprotegerin ligand system in the human bone marrow environment. Blood 98(13):3527\u20133533","journal-title":"Blood"},{"issue":"2","key":"9108_CR16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1182\/blood.V96.2.671","volume":"96","author":"SJ Choi","year":"2000","unstructured":"Choi SJ, Cruz JC, Craig F, Chung H, Devlin RD, Roodman GD, Alsina M (2000) Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood 96(2):671\u2013675","journal-title":"Blood"},{"issue":"6","key":"9108_CR17","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood.V100.6.2195","volume":"100","author":"M Abe","year":"2002","unstructured":"Abe M, Hiura K, Wilde J, Moriyama K, Hashimoto T, Ozaki S, Wakatsuki S, Kosaka M, Kido S, Inoue D, Matsumoto T (2002) Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma. Blood 100(6):2195\u20132202","journal-title":"Blood"},{"issue":"3","key":"9108_CR18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.exphem.2004.11.015","volume":"33","author":"Y Oba","year":"2005","unstructured":"Oba Y, Lee JW, Ehrlich LA, Chung HY, Jelinek DF, Callander NS, Horuk R, Choi SJ, Roodman GD (2005) MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells. Exp Hematol 33(3):272\u2013278","journal-title":"Exp Hematol"},{"issue":"5","key":"9108_CR19","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1158\/0008-5472.CAN-04-1687","volume":"65","author":"AC Zannettino","year":"2005","unstructured":"Zannettino AC, Farrugia AN, Kortesidis A, Manavis J, To LB, Martin SK, Diamond P, Tamamura H, Lapidot T, Fujii N, Gronthos S (2005) Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients. Cancer Res 65(5):1700\u20131709","journal-title":"Cancer Res"},{"issue":"5","key":"9108_CR20","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1182\/blood.V96.5.1953","volume":"96","author":"T Michigami","year":"2000","unstructured":"Michigami T, Shimizu N, Williams PJ, Niewolna M, Dallas SL, Mundy GR, Yoneda T (2000) Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity. Blood 96(5):1953\u20131960","journal-title":"Blood"},{"issue":"1","key":"9108_CR21","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/blood.V74.1.380.380","volume":"74","author":"F Cozzolino","year":"1989","unstructured":"Cozzolino F, Torcia M, Aldinucci D, Rubartelli A, Miliani A, Shaw AR, Lansdorp PM, Di Guglielmo R (1989) Production of interleukin-1 by bone marrow myeloma cells. Blood 74(1):380\u2013387","journal-title":"Blood"},{"issue":"4","key":"9108_CR22","first-page":"546","volume":"11","author":"S Barille","year":"2000","unstructured":"Barille S, Bataille R, Amiot M (2000) The role of interleukin-6 and interleukin-6\/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma. Eur Cytokine Netw 11(4):546\u2013551","journal-title":"Eur Cytokine Netw"},{"issue":"9","key":"9108_CR23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJM198708273170902","volume":"317","author":"IR Garrett","year":"1987","unstructured":"Garrett IR, Durie BG, Nedwin GE, Gillespie A, Bringman T, Sabatini M, Bertolini DR, Mundy GR (1987) Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells. N Engl J Med 317(9):526\u2013533","journal-title":"N Engl J Med"},{"issue":"6","key":"9108_CR24","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1182\/blood-2003-06-1992","volume":"103","author":"JW Lee","year":"2004","unstructured":"Lee JW, Chung HY, Ehrlich LA, Jelinek DF, Callander NS, Roodman GD, Choi SJ (2004) IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells. Blood 103(6):2308\u20132315","journal-title":"Blood"},{"issue":"26","key":"9108_CR25","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","volume":"349","author":"E Tian","year":"2003","unstructured":"Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD Jr (2003) The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 349(26):2483\u20132494","journal-title":"N Engl J Med"},{"issue":"7","key":"9108_CR26","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1182\/blood-2004-12-4986","volume":"106","author":"N Giuliani","year":"2005","unstructured":"Giuliani N, Colla S, Morandi F, Lazzaretti M, Sala R, Bonomini S, Grano M, Colucci S, Svaldi M, Rizzoli V (2005) Myeloma cells block RUNX2\/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation. Blood 106(7):2472\u20132483","journal-title":"Blood"},{"issue":"8","key":"9108_CR27","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood-2003-11-3839","volume":"104","author":"M Abe","year":"2004","unstructured":"Abe M, Hiura K, Wilde J, Shioyasono A, Moriyama K, Hashimoto T, Kido S, Oshima T, Shibata H, Ozaki S, Inoue D, Matsumoto T (2004) Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion. Blood 104(8):2484\u20132491","journal-title":"Blood"},{"issue":"2","key":"9108_CR28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.leu.2404067","volume":"20","author":"A Vacca","year":"2006","unstructured":"Vacca A, Ribatti D (2006) Bone marrow angiogenesis in multiple myeloma. Leukemia 20(2):193\u2013199","journal-title":"Leukemia"},{"issue":"7","key":"9108_CR29","first-page":"2210","volume":"8","author":"SV Rajkumar","year":"2002","unstructured":"Rajkumar SV, Mesa RA, Fonseca R, Schroeder G, Plevak MF, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Gertz MA, Kyle RA, Russell SJ, Greipp PR (2002) Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. Clin Cancer Res 8(7):2210\u20132216","journal-title":"Clin Cancer Res"},{"issue":"8","key":"9108_CR30","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1182\/blood-2003-08-2946","volume":"103","author":"K Asosingh","year":"2004","unstructured":"Asosingh K, De Raeve H, Menu E, Van Riet I, Van Marck E, Van Camp B, Vanderkerken K (2004) Angiogenic switch during 5T2MM murine myeloma tumorigenesis: role of CD45 heterogeneity. Blood 103(8):3131\u20133137","journal-title":"Blood"},{"issue":"3","key":"9108_CR31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.1994.tb08304.x","volume":"87","author":"A Vacca","year":"1994","unstructured":"Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, Dammacco F (1994) Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 87(3):503\u2013508","journal-title":"Br J Haematol"},{"issue":"3","key":"9108_CR32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.bmt.1704555","volume":"34","author":"S Kumar","year":"2004","unstructured":"Kumar S, Gertz MA, Dispenzieri A, Lacy MQ, Wellik LA, Fonseca R, Lust JA, Witzig TE, Kyle RA, Greipp PR, Rajkumar SV (2004) Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy. Bone Marrow Transplant 34(3):235\u2013239","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"9108_CR33","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s002770000236","volume":"79","author":"O Sezer","year":"2000","unstructured":"Sezer O, Niemoller K, Eucker J, Jakob C, Kaufmann O, Zavrski I, Dietel M, Possinger K (2000) Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma. Ann Hematol 79(10):574\u2013577","journal-title":"Ann Hematol"},{"issue":"8","key":"9108_CR34","first-page":"3111","volume":"6","author":"SV Rajkumar","year":"2000","unstructured":"Rajkumar SV, Leong T, Roche PC, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Kyle RA, Gertz MA, Greipp PR (2000) Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res 6(8):3111\u20133116","journal-title":"Clin Cancer Res"},{"issue":"3","key":"9108_CR35","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1365-2141.2002.03654.x","volume":"118","author":"G Pruneri","year":"2002","unstructured":"Pruneri G, Ponzoni M, Ferreri AJ, Decarli N, Tresoldi M, Raggi F, Baldessari C, Freschi M, Baldini L, Goldaniga M, Neri A, Carboni N, Bertolini F, Viale G (2002) Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients. Br J Haematol 118(3):817\u2013822","journal-title":"Br J Haematol"},{"issue":"8","key":"9108_CR36","first-page":"800","volume":"85","author":"F Raimondo Di","year":"2000","unstructured":"Di Raimondo F, Azzaro MP, Palumbo G, Bagnato S, Giustolisi G, Floridia P, Sortino G, Giustolisi R (2000) Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood. Haematologica 85(8):800\u2013805","journal-title":"Haematologica"},{"issue":"8","key":"9108_CR37","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1182\/blood.V95.8.2630","volume":"95","author":"B Dankbar","year":"2000","unstructured":"Dankbar B, Padro T, Leo R, Feldmann B, Kropff M, Mesters RM, Serve H, Berdel WE, Kienast J (2000) Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. Blood 95(8):2630\u20132636","journal-title":"Blood"},{"issue":"7","key":"9108_CR38","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/blood-2002-09-2813","volume":"101","author":"YT Tai","year":"2003","unstructured":"Tai YT, Podar K, Mitsiades N, Lin B, Mitsiades C, Gupta D, Akiyama M, Catley L, Hideshima T, Munshi NC, Treon SP, Anderson KC (2003) CD40 induces human multiple myeloma cell migration via phosphatidylinositol 3-kinase\/AKT\/NF-kappa B signaling. Blood 101(7):2762\u20132769","journal-title":"Blood"},{"key":"9108_CR39","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1182\/blood.V98.2.428","volume":"98","author":"K Podar","year":"2001","unstructured":"Podar K, Tai YT, Davies FE, Lentzsch S, Sattler M, Hideshima T, Lin BK, Gupta D, Shima Y, Chauhan D, Mitsiades C, Raje N, Richardson P, Anderson KC (2001) Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration. Blood 98:428\u2013435","journal-title":"Blood"},{"issue":"10","key":"9108_CR40","doi-asserted-by":"crossref","first-page":"7875","DOI":"10.1074\/jbc.M109068200","volume":"277","author":"K Podar","year":"2002","unstructured":"Podar K, Tai YT, Lin BK, Narsimhan RP, Sattler M, Kijima T, Salgia R, Gupta D, Chauhan D, Anderson KC (2002) Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activation. J Biol Chem 277(10):7875\u20137881","journal-title":"J Biol Chem"},{"issue":"2","key":"9108_CR41","first-page":"176","volume":"88","author":"A Vacca","year":"2003","unstructured":"Vacca A, Ria R, Ribatti D, Semeraro F, Djonov V, Di Raimondo F, Dammacco F (2003) A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma. Haematologica 88(2):176\u2013185","journal-title":"Haematologica"},{"issue":"12","key":"9108_CR42","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/sj.leu.2402295","volume":"15","author":"D Gupta","year":"2001","unstructured":"Gupta D, Treon SP, Shima Y, Hideshima T, Podar K, Tai YT, Lin B, Lentzsch S, Davies FE, Chauhan D, Schlossman RL, Richardson P, Ralph P, Wu L, Payvandi F, Muller G, Stirling DI, Anderson KC (2001) Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications. Leukemia 15(12):1950\u20131961","journal-title":"Leukemia"},{"issue":"3","key":"9108_CR43","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.leu.2403269","volume":"18","author":"N Giuliani","year":"2004","unstructured":"Giuliani N, Lunghi P, Morandi F, Colla S, Bonomini S, Hojden M, Rizzoli V, Bonati A (2004) Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis. Leukemia 18(3):628\u2013635","journal-title":"Leukemia"},{"issue":"7","key":"9108_CR44","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1182\/blood-2002-09-2907","volume":"101","author":"G Bisping","year":"2003","unstructured":"Bisping G, Leo R, Wenning D, Dankbar B, Padro T, Kropff M, Scheffold C, Kroger M, Mesters RM, Berdel WE, Kienast J (2003) Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma. Blood 101(7):2775\u20132783","journal-title":"Blood"},{"issue":"12","key":"9108_CR45","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/sj.leu.2403976","volume":"19","author":"S Colla","year":"2005","unstructured":"Colla S, Morandi F, Lazzaretti M, Rizzato R, Lunghi P, Bonomini S, Mancini C, Pedrazzoni M, Crugnola M, Rizzoli V, Giuliani N (2005) Human myeloma cells express the bone regulating gene Runx2\/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients. Leukemia 19(12):2166\u20132176","journal-title":"Leukemia"},{"issue":"2","key":"9108_CR46","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood-2002-10-3257","volume":"102","author":"N Giuliani","year":"2003","unstructured":"Giuliani N, Colla S, Lazzaretti M, Sala R, Roti G, Mancini C, Bonomini S, Lunghi P, Hojden M, Genestreti G, Svaldi M, Coser P, Fattori PP, Sammarelli G, Gazzola GC, Bataille R, Almici C, Caramatti C, Mangoni L, Rizzoli V (2003) Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis. Blood 102(2):638\u2013645","journal-title":"Blood"},{"issue":"3","key":"9108_CR47","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1158\/1078-0432.CCR-06-2258","volume":"13","author":"Y Tanaka","year":"2007","unstructured":"Tanaka Y, Abe M, Hiasa M, Oda A, Amou H, Nakano A, Takeuchi K, Kitazoe K, Kido S, Inoue D, Moriyama K, Hashimoto T, Ozaki S, Matsumoto T (2007) Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin. Clin Cancer Res 13(3):816\u2013823","journal-title":"Clin Cancer Res"},{"key":"9108_CR48","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1146\/annurev.iy.10.040192.003021","volume":"10","author":"LJ Picker","year":"1992","unstructured":"Picker LJ, Butcher EC (1992) Physiological and molecular mechanisms of lymphocyte homing. Annu Rev Immunol 10:561\u2013591","journal-title":"Annu Rev Immunol"},{"issue":"5258","key":"9108_CR49","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1126\/science.272.5258.60","volume":"272","author":"EC Butcher","year":"1996","unstructured":"Butcher EC, Picker LJ (1996) Lymphocyte homing and homeostasis. Science 272(5258):60\u201366","journal-title":"Science"},{"issue":"4","key":"9108_CR50","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1054\/bjoc.1999.1024","volume":"82","author":"K Vanderkerken","year":"2000","unstructured":"Vanderkerken K, De Greef C, Asosingh K, Arteta B, De Veerman M, Vande Broek I, Van Riet I, Kobayashi M, Smedsrod B, Van Camp B (2000) Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL\/KalwRij mouse. Br J Cancer 82(4):953\u2013959","journal-title":"Br J Cancer"},{"issue":"11","key":"9108_CR51","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.exphem.2004.07.019","volume":"32","author":"E Alici","year":"2004","unstructured":"Alici E, Konstantinidis KV, Aints A, Dilber MS, Abedi-Valugerdi M (2004) Visualization of 5T33 myeloma cells in the C57BL\/KaLwRij mouse: establishment of a new syngeneic murine model of multiple myeloma. Exp Hematol 32(11):1064\u20131072","journal-title":"Exp Hematol"},{"issue":"6","key":"9108_CR52","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3109\/10428199309145751","volume":"9","author":"I Riet Van","year":"1993","unstructured":"Van Riet I, Van Camp B (1993) The involvement of adhesion molecules in the biology of multiple myeloma. Leuk Lymphoma 9(6):441\u2013452","journal-title":"Leuk Lymphoma"},{"key":"9108_CR53","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF02821934","volume":"15","author":"I Riet Van","year":"1998","unstructured":"Van Riet I, Vanderkerken K, de Greef C, Van Camp B (1998) Homing behaviour of the malignant cell clone in multiple myeloma. Med Oncol 15:154\u2013164","journal-title":"Med Oncol"},{"issue":"1","key":"9108_CR54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0301-472X(00)00625-1","volume":"29","author":"K Asosingh","year":"2001","unstructured":"Asosingh K, De Raeve H, Croucher P, Goes E, Van Riet I, Van Camp B, Vanderkerken K (2001) In vivo homing and differentiation characteristics of mature (CD45\u2212) and immature (CD45+) 5T multiple myeloma cells. Exp Hematol 29(1):77\u201386","journal-title":"Exp Hematol"},{"issue":"2","key":"9108_CR55","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/blood.V97.2.346","volume":"97","author":"F Sanz-Rodriguez","year":"2001","unstructured":"Sanz-Rodriguez F, Hidalgo A, Teixido J (2001) Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin mediated multiple myeloma cell adhesion to CS-1\/fibronectin and VCAM-1. Blood 97(2):346\u2013351","journal-title":"Blood"},{"issue":"7","key":"9108_CR56","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1023\/A:1006715504719","volume":"17","author":"T Okada","year":"1999","unstructured":"Okada T, Hawley RG, Kodaka M, Okuno H (1999) Significance of VLA-4-VCAM-1 interaction and CD44 for transendothelial invasion in a bone marrow metastatic myeloma model. Clin Exp Metastasis 17(7):623\u2013629","journal-title":"Clin Exp Metastasis"},{"issue":"18","key":"9108_CR57","first-page":"4376","volume":"53","author":"J Klominek","year":"1993","unstructured":"Klominek J, Robert KH, Sundqvist KG (1993) Chemotaxis and haptotaxis of human malignant mesothelioma cells: effects of fibronectin, laminin, type IV collagen, and an autocrine motility factor-like substance. Cancer Res 53(18):4376\u20134382","journal-title":"Cancer Res"},{"issue":"4","key":"9108_CR58","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/path.1396","volume":"200","author":"JA Engbring","year":"2003","unstructured":"Engbring JA, Kleinman HK (2003) The basement membrane matrix in malignancy. J Pathol 200(4):465\u2013470","journal-title":"J Pathol"},{"issue":"9","key":"9108_CR59","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1054\/bjoc.2001.2078","volume":"85","author":"I Broek Vande","year":"2001","unstructured":"Vande Broek I, Vanderkerken K, De Greef C, Asosingh K, Straetmans N, Van Camp B, Van Riet I (2001) Laminin-1-induced migration of multiple myeloma cells involves the high-affinity 67 kD laminin receptor. Br J Cancer 85(9):1387\u20131395","journal-title":"Br J Cancer"},{"key":"9108_CR60","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1083\/jcb.96.5.1475","volume":"96","author":"HL Malinoff","year":"1983","unstructured":"Malinoff HL, Wicha MS (1983) Isolation of a cell surface receptor protein for laminin from murine fibrosarcoma cells. J Cell Biol 96:1475\u20131479","journal-title":"J Cell Biol"},{"issue":"1","key":"9108_CR61","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1006\/bbrc.1994.1713","volume":"201","author":"FA Brule van den","year":"1994","unstructured":"van den Brule FA, Price J, Sobel ME, Lambotte R, Castronovo V (1994) Inverse expression of two laminin binding proteins, 67LR and galectin-3, correlates with the invasive phenotype of trophoblastic tissue. Biochem Biophys Res Commun 201(1):388\u2013393","journal-title":"Biochem Biophys Res Commun"},{"key":"9108_CR62","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/A:1006171403765","volume":"52","author":"S Menard","year":"1998","unstructured":"Menard S, Tagliabue E, Colnaghi MI (1998) The 67 kDa laminin receptor as a prognostic factor in human cancer. Breast Cancer Res Treat 52:137\u2013145","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"9108_CR63","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.gene.2004.09.002","volume":"343","author":"H Boukerche","year":"2004","unstructured":"Boukerche H, Su ZZ, Kang DC, Fisher PB (2004) Identification and cloning of genes displaying elevated expression as a consequence of metastatic progression in human melanoma cells by rapid subtraction hybridization. Gene 343(1):191\u2013201","journal-title":"Gene"},{"issue":"7","key":"9108_CR64","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1182\/blood-2005-11-012625","volume":"108","author":"C Selleri","year":"2006","unstructured":"Selleri C, Ragno P, Ricci P, Visconte V, Scarpato N, Carriero MV, Rotoli B, Rossi G, Montuori N (2006) The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. Blood 108(7):2476\u20132484","journal-title":"Blood"},{"key":"9108_CR65","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/0092-8674(87)90707-0","volume":"48","author":"J Graf","year":"1987","unstructured":"Graf J, Iwamoto Y, Sasaki M, Martin GR, Kleinman HK, Robey FA, Yamada Y (1987) Identification of an amino acid sequence in laminin mediating cell attachment, chemotaxis, and receptor binding. Cell 48:989\u2013996","journal-title":"Cell"},{"issue":"6","key":"9108_CR66","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.bjc.6600833","volume":"88","author":"I Broek Vande","year":"2003","unstructured":"Vande Broek I, Asosingh K, Vanderkerken K, Straetmans N, Van Camp B, Van Riet I (2003) Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3. Br J Cancer 88(6):855\u2013862","journal-title":"Br J Cancer"},{"issue":"1","key":"9108_CR67","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.leu.2402717","volume":"17","author":"C Moller","year":"2003","unstructured":"Moller C, Stromberg T, Juremalm M, Nilsson K, Nilsson G (2003) Expression and function of chemokine receptors in human multiple myeloma. Leukemia 17(1):203\u2013210","journal-title":"Leukemia"},{"issue":"3","key":"9108_CR68","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4049\/jimmunol.170.3.1136","volume":"170","author":"T Nakayama","year":"2003","unstructured":"Nakayama T, Hieshima K, Izawa D, Tatsumi Y, Kanamaru A, Yoshie O (2003) Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues. J Immunol 170(3):1136\u20131140","journal-title":"J Immunol"},{"issue":"2","key":"9108_CR69","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.canlet.2003.10.036","volume":"207","author":"A Pellegrino","year":"2004","unstructured":"Pellegrino A, Antonaci F, Russo F, Merchionne F, Ribatti D, Vacca A, Dammacco F (2004) CXCR3-binding chemokines in multiple myeloma. Cancer Lett 207(2):221\u2013227","journal-title":"Cancer Lett"},{"issue":"5","key":"9108_CR70","first-page":"605","volume":"91","author":"E Menu","year":"2006","unstructured":"Menu E, Asosingh K, Indraccolo S, De Raeve H, Van Riet I, Van Valckenborgh E, Vande Broek I, Fujii N, Tamamura H, Van Camp B, Vanderkerken K (2006) The involvement of stromal derived factor 1 alpha in homing and progression of multiple myeloma in the 5TMM model. Haematologica 91(5):605\u2013612","journal-title":"Haematologica"},{"issue":"5\u20136","key":"9108_CR71","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10585-006-9038-6","volume":"23","author":"E Menu","year":"2006","unstructured":"Menu E, De Leenheer E, De Raeve H, Coulton L, Imanishi T, Miyashita K, Van Valckenborgh E, Van Riet I, Van Camp B, Horuk R, Croucher P, Vanderkerken K (2006) Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model. Clin Exp Metastasis 23(5\u20136):291\u2013300","journal-title":"Clin Exp Metastasis"},{"key":"9108_CR72","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood-2006-07-035857","volume":"109","author":"Y Alsayed","year":"2007","unstructured":"Alsayed Y, Ngo H, Runnels J, Leleu X, Singha UK, Pitsillides CM, Spencer JA, Kimlinger T, Ghobrial JM, Jia X, Lu G, Timm M, Kumar A, Cote D, Veilleux I, Hedin KE, Roodman GD, Witzig TE, Kung AL, Hideshima T, Anderson KC, Lin CP, Ghobrial IM (2007) Mechanisms of regulation of CXCR4\/SDF-1 (CXCL12) dependent migration and homing in multiple myeloma. Blood 109:2708\u20132717","journal-title":"Blood"},{"issue":"11","key":"9108_CR73","first-page":"1489","volume":"91","author":"N Giuliani","year":"2006","unstructured":"Giuliani N, Bonomini S, Romagnani P, Lazzaretti M, Morandi F, Colla S, Tagliaferri S, Lasagni L, Annunziato F, Crugnola M, Rizzoli V (2006) CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival. Haematologica 91(11):1489\u20131497","journal-title":"Haematologica"},{"issue":"10","key":"9108_CR74","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1038\/sj.leu.2402714","volume":"16","author":"BK Arendt","year":"2002","unstructured":"Arendt BK, Velazquez-Dones A, Tschumper RC, Howell KG, Ansell SM, Witzig TE, Jelinek DF (2002) Interleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cells. Leukemia 16(10):2142\u20132147","journal-title":"Leukemia"},{"issue":"7","key":"9108_CR75","first-page":"539","volume":"1","author":"T Hideshima","year":"2002","unstructured":"Hideshima T, Chauhan D, Hayashi T, Podar K, Akiyama M, Gupta D, Richardson P, Munshi N, Anderson KC 2002) The biological sequelae of stromal cell-derived factor-1alpha in multiple myeloma. Mol Cancer Ther 1(7):539\u2013544","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"9108_CR76","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.yexcr.2003.12.003","volume":"294","author":"M Parmo-Cabanas","year":"2004","unstructured":"Parmo-Cabanas M, Bartolome RA, Wright N, Hidalgo A, Drager AM, Teixido J (2004) Integrin alpha4beta1 involvement in stromal cell-derived factor-1alpha-promoted myeloma cell transendothelial migration and adhesion: role of cAMP and the actin cytoskeleton in adhesion. Exp Cell Res 294(2):571\u2013580","journal-title":"Exp Cell Res"},{"key":"9108_CR77","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/sj.leu.2402295","volume":"15","author":"D Gupta","year":"2001","unstructured":"Gupta D, Treon SP, Shima Y, Hideshima T, Podar K, Tai YT, Lin B, Lentzsch S, Davies FE, Chauhan D, Schlossman RL, Richardson P, Ralph P, Wu L, Payvandi F, Muller G, Stirling DI, Anderson KC (2001) Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications. Leukemia 15:1950\u20131961","journal-title":"Leukemia"},{"issue":"1","key":"9108_CR78","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1182\/blood.V93.1.235","volume":"93","author":"K Vanderkerken","year":"1999","unstructured":"Vanderkerken K, Asosingh K, Braet F, Van Riet I, Van Camp B (1999) Insulin-like growth factor-1 acts as a chemoattractant factor for 5T2 multiple myeloma cells. Blood 93(1):235\u2013241","journal-title":"Blood"},{"issue":"5","key":"9108_CR79","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/sj.bjc.6601613","volume":"90","author":"E Menu","year":"2004","unstructured":"Menu E, Kooijman R, Van Valckenborgh E, Asosingh K, Bakkus M, Van Camp B, Vanderkerken K (2004) Specific roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model. Br J Cancer 90(5):1076\u20131083","journal-title":"Br J Cancer"},{"issue":"1","key":"9108_CR80","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood-2003-06-2066","volume":"103","author":"YW Qiang","year":"2004","unstructured":"Qiang YW, Yao L, Tosato G, Rudikoff S (2004) Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells. Blood 103(1):301\u2013308","journal-title":"Blood"},{"issue":"5","key":"9108_CR81","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1182\/blood-2005-01-0049","volume":"106","author":"YW Qiang","year":"2005","unstructured":"Qiang YW, Walsh K, Yao L, Kedei N, Blumberg PM, Rubin JS, Shaughnessy J Jr, Rudikoff S (2005) Wnts induce migration and invasion of myeloma plasma cells. Blood 106(5):1786\u20131793","journal-title":"Blood"},{"key":"9108_CR82","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ijc.10642","volume":"101","author":"E Valckenborgh Van","year":"2002","unstructured":"Van Valckenborgh E, Bakkus M, Munaut C, Noel A, St Pierre Y, Asosingh K, Van Riet I, Van Camp B, Vanderkerken K (2002) Upregulation of matrix metalloproteinase-9 in murine 5T33 multiple myeloma cells by interaction with bone marrow endothelial cells. Int J Cancer 101:512\u2013518","journal-title":"Int J Cancer"},{"issue":"5","key":"9108_CR83","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/sj.leu.2403331","volume":"18","author":"I Broek Vande","year":"2004","unstructured":"Vande Broek I, Asosingh K, Allegaert V, Leleu X, Facon T, Vanderkerken K, Van Camp B, Van Riet I (2004) Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor. Leukemia 18(5):976\u2013982","journal-title":"Leukemia"},{"key":"9108_CR84","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1182\/blood.V90.4.1649","volume":"90","author":"S Barille","year":"1997","unstructured":"Barille S, Akhoundi C, Collette M, Mellerin MP, Rapp MJ, Harousseau JL, Bataille R, Amiot M (1997) Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells. Blood 90:1649\u20131655","journal-title":"Blood"},{"key":"9108_CR85","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1023\/A:1020987830132","volume":"19","author":"K Asosingh","year":"2002","unstructured":"Asosingh K, Menu E, Van Valckenborgh E, Vande Broek I, Van Riet I, Van Camp B, Vanderkerken K (2002) Mechanisms involved in the differential bone marrow homing of CD45 subsets in 5T murine models of myeloma. Clin Exp Metastasis 19:583\u2013591","journal-title":"Clin Exp Metastasis"},{"key":"9108_CR86","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1096\/fasebj.13.8.781","volume":"13","author":"J Westermarck","year":"1999","unstructured":"Westermarck J, Kahari VM (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13:781\u2013792","journal-title":"FASEB J"},{"key":"9108_CR87","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0955-2235(91)90014-U","volume":"3","author":"T Nakamura","year":"1991","unstructured":"Nakamura T (1991) Structure and function of hepatocyte growth factor. Prog Growth Factor Res 3:67\u201385","journal-title":"Prog Growth Factor Res"},{"key":"9108_CR88","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1006\/bbrc.2001.5521","volume":"286","author":"Y Jiang","year":"2001","unstructured":"Jiang Y, Xu W, Lu J, He F, Yang X (2001) Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1. Biochem Biophys Res Commun 286:1123\u20131130","journal-title":"Biochem Biophys Res Commun"},{"key":"9108_CR89","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ijc.1595","volume":"97","author":"A Monvoisin","year":"2002","unstructured":"Monvoisin A, Bisson C, Si-Tayeb K, Balabaud C, Desmouliere A, Rosenbaum J (2002) Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells. Int J Cancer 97:157\u2013162","journal-title":"Int J Cancer"},{"key":"9108_CR90","doi-asserted-by":"crossref","first-page":"24655","DOI":"10.1074\/jbc.271.40.24655","volume":"271","author":"M Borset","year":"1996","unstructured":"Borset M, Lien E, Espevik T, Helseth E, Waage A, Sundan A (1996) Concomitant expression of hepatocyte growth factor\/scatter factor and the receptor c-Met in human myeloma cell lines. J Biol Chem 271:24655\u201324661","journal-title":"J Biol Chem"},{"key":"9108_CR91","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/sj.leu.2402875","volume":"17","author":"PW Derksen","year":"2003","unstructured":"Derksen PW, de Gorter DJ, Meijer HP, Bende RJ, van Dijk M, Lokhorst HM, Bloem AC, Spaargaren M, Pals ST (2003) The hepatocyte growth factor\/Met pathway controls proliferation and apoptosis in multiple myeloma. Leukemia 17:764\u2013774","journal-title":"Leukemia"},{"key":"9108_CR92","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood.V99.4.1405","volume":"99","author":"PW Derksen","year":"2002","unstructured":"Derksen PW, Keehnen RM, Evers LM, van Oers MH, Spaargaren M, Pals ST (2002) Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma. Blood 99:1405\u20131410","journal-title":"Blood"},{"issue":"2","key":"9108_CR93","first-page":"200","volume":"91","author":"I Broek Vande","year":"2006","unstructured":"Vande Broek I, Leleu X, Schots R, Facon T, Vanderkerken K, Van Camp B, Van Riet I (2006) Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survival. Haematologica 91(2):200\u2013206","journal-title":"Haematologica"},{"key":"9108_CR94","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/sj.bjc.6690186","volume":"79","author":"S Uchida","year":"1999","unstructured":"Uchida S, Shimada Y, Watanabe G, Li ZG, Hong T, Miyake M, Imamura M (1999) Motility-related protein (MRP-1\/CD9) and KAI1\/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer 79:1168\u20131173","journal-title":"Br J Cancer"},{"key":"9108_CR95","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/carcin\/bgi209","volume":"27","author":"L Drucker","year":"2006","unstructured":"Drucker L, Tohami T, Tartakover-Matalon S, Zismanov V, Shapiro H, Radnay J, Lishner M (2006) Promoter hypermethylation of tetraspanin members contributes to their silencing in myeloma cell lines. Carcinogenesis 27:197\u2013204","journal-title":"Carcinogenesis"},{"issue":"3","key":"9108_CR96","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1096\/fj.06-6610com","volume":"21","author":"T Tohami","year":"2007","unstructured":"Tohami T, Drucker L, Shapiro H, Radnay J, Lishner M (2007) Overexpression of tetraspanins affects multiple myeloma cell survival and invasive potential. FASEB J 21(3):691\u2013699","journal-title":"FASEB J"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-007-9108-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-007-9108-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-007-9108-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T03:46:39Z","timestamp":1587959199000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-007-9108-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,19]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["9108"],"URL":"https:\/\/doi.org\/10.1007\/s10585-007-9108-4","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,19]]}}}